Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AACR 2021
Research
AACR: MD Anderson team uncovers new target in pancreatic cancer
Mutant KRAS and p53 rely on the protein CREB1 to drive pancreatic cancer, an MD Anderson team found.
Arlene Weintraub
Apr 12, 2021 8:35am
Sanofi's engineered IL-2 clears safety hurdles in early data
Apr 12, 2021 8:20am
OncoMyx's modified rabbit pox virus shows promise in lung cancer
Apr 12, 2021 7:55am
AACR: Zentalis' WEE1 inhibitor shows promise in phase 1
Apr 10, 2021 1:30pm
